RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes

Clinical trial NCT00809185 · TERMINATED

Trial details

NCT number: NCT00809185
Sponsor: Case Comprehensive Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2005-11-01
Primary completion: 2009-02-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.